NOK 0.55
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | -66.9 Million | -81.33 Million | -37.75 Million | -24.19 Million | -2.33 Million |
Net Income | -117.66 Million | -93.08 Million | -52.99 Million | -27.22 Million | -2.62 Million |
Depreciation & Amortization | 13.37 Million | 12.89 Million | 7.29 Million | 865.09 Thousand | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 281.97 Thousand | 1.39 Million | 5.77 Million | - | - |
Change in working capital | 27.06 Million | 5.71 Million | 3.21 Million | 1.23 Million | 285.64 Thousand |
Other non-cash items | 8.26 Million | 18.5 Million | 10.24 Million | 2.17 Million | 4.64 Million |
Investing Cash Flow | -62.54 Million | -104.68 Million | -36.71 Million | -19.38 Million | -4.07 Million |
Investments in PPE | -62.54 Million | -90.63 Million | -36.28 Million | -13.56 Million | -4.07 Million |
Acquisitions | - | - | - | -5.82 Million | - |
Investment purchases | - | -14.04 Million | -438.35 Thousand | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | -60.41 Million | -103.03 Million | -35.86 Million | -100 Thousand | -15.58 Million |
Financing Cash Flow | 82.45 Million | 173.54 Million | 93.27 Million | 83.6 Million | 10.09 Million |
Debt repayment | -24.06 Million | -98.35 Million | -4.69 Million | -9.2 Million | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 18 Million | 82.93 Million | 96.21 Million | 74.88 Million | 10.09 Million |
Other Financing Activities | 52.77 Million | 1.47 Million | 1.04 Million | 83.91 Million | 40.39 Million |
Accounts receivables | 1.48 Million | -332.08 Thousand | -4.41 Million | 82.69 Thousand | -4.64 Million |
Accounts payables | 36.15 Million | -760.08 Thousand | 15.9 Million | 6.48 Million | - |
Inventory | -8.83 Million | 1.51 Million | -2.4 Million | -6.08 Million | - |
Other working capital | -1.73 Million | 5.29 Million | -5.86 Million | 746.99 Thousand | 4.93 Million |
Cash at beginning of period | 47.15 Million | 59.61 Million | 43.71 Million | 3.68 Million | 1.00 |
Cash at end of period | 165.46 Thousand | 47.15 Million | 59.61 Million | 43.71 Million | 3.68 Million |
Capital Expenditure | -62.54 Million | -90.63 Million | -36.28 Million | -13.56 Million | -4.07 Million |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -46.98 Million | -12.46 Million | 15.9 Million | 40.02 Million | 3.68 Million |
Free Cash Flow | -129.44 Million | -171.96 Million | -74.03 Million | -37.75 Million | -6.41 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -58.66 Million | -58.66 Million | -117.66 Million | -39 Million | -22.2 Million | -28.94 Million |
Depreciation & Amortization | 3.07 Million | 3.07 Million | 13.37 Million | 3.76 Million | 3.37 Million | 3.13 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 9726.00 | 9726.00 | 281.97 Thousand | 55.97 Thousand | 55.86 Thousand | 55.13 Thousand |
Change in working capital | 5.93 Million | 5.93 Million | 27.06 Million | 3.79 Million | 15.94 Million | 917.86 Thousand |
Other non-cash items | 39.93 Million | 39.93 Million | 8.26 Million | 5.75 Million | -35.18 Million | -3.92 Million |
Investing Cash Flow | -3.37 Million | -3.37 Million | -62.54 Million | 2.66 Million | -7.17 Million | -12.68 Million |
Investments in PPE | -20.28 Thousand | -20.28 Thousand | -62.54 Million | -217.06 Thousand | -6.57 Million | -14.06 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -3.35 Million | -3.35 Million | -60.41 Million | 2.87 Million | -601.17 Thousand | 1.38 Million |
Financing Cash Flow | 14.39 Million | 14.39 Million | 82.45 Million | 23.54 Million | 632.79 Thousand | 36 Million |
Debt repayment | - | - | -24.06 Million | -21.56 Million | -9.53 Million | -377.4 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | -1.92 Million |
Common Stock Issuance | - | - | 18 Million | -39.25 Million | 13.12 Million | -1.92 Million |
Other Financing Activities | 14.39 Million | 14.39 Million | 52.77 Million | 21.99 Million | 752.25 Thousand | 28.63 Million |
Accounts receivables | 4.69 Million | 4.69 Million | 1.48 Million | -28.08 Million | 28.74 Million | -4.7 Million |
Accounts payables | - | - | 36.15 Million | - | - | 14.97 Million |
Inventory | -2.25 Million | -2.25 Million | -8.83 Million | -3.33 Million | -2.08 Million | -5.08 Million |
Other working capital | 3.49 Million | 3.49 Million | -1.73 Million | -942.13 Thousand | 9.79 Million | -9.79 Million |
Cash at beginning of period | - | 165.46 Thousand | 47.15 Million | 389 Thousand | 2.87 Million | 4.75 Million |
Cash at end of period | 1.3 Million | 1.46 Million | 165.46 Thousand | 165.46 Thousand | 389 Thousand | 2.87 Million |
Capital Expenditure | -20.28 Thousand | -20.28 Thousand | -62.54 Million | -217.06 Thousand | -6.57 Million | -14.06 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 1.3 Million | 1.3 Million | -46.98 Million | -223.53 Thousand | -2.49 Million | -1.87 Million |
Free Cash Flow | -9.73 Million | -9.73 Million | -129.44 Million | -26.65 Million | -2.52 Million | -39.27 Million |
MTEN
TAR
1432
JPAVF
FFARMS
CVE